$73.72
5.34%
Nasdaq, Nov 16, 04:00 pm EST. Closed.
ISIN
US14167L1035
Symbol
CDNA

CareDx, Inc. Stock price

$73.72
+9.72 15.19% 1M
+53.13 258.04% 6M
+54.88 291.30% YTD
+58.21 375.31% 1Y
+64.59 707.45% 3Y
+26.22 55.20% 5Y
+70.37 2,100.60% 10Y
+64.67 714.59% 20Y
Nasdaq, Closing price Mon, Nov 16 2026
-4.16 5.34%
ISIN
US14167L1035
Symbol
CDNA
Industry

Is CareDx, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.

Key metrics

Basic
Market capitalization
$4.1b
Enterprise Value
$3.8b
Net debt
positive
Cash
$250.5m
Shares outstanding
52.5m
Valuation
P/E
33.4
P/S | estimate
8.2 | 7.7
EV/Sales | estimate
7.7 | 7.2
EV/FCF | ex SBC
64.3 | 178.3
P/B
8.8
Financial Health
Equity Ratio
73.4%
Return on Equity
-7.1%
ROCE
23.8%
ROIC
39.1%
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$38.2m | 7.7%
SBC as % of FCF
63.9%
SBC Growth 1Y
-27.9%
Share Count Growth 1Y
2.0%
Shareholder Yield
-2.0%
Financials
Revenue | estimate
$497.4m | $531.5m
EBITDA
$121.7m
EBIT
$119.4m
Net Income
$128.6m
Free Cash Flow | ex SBC
$59.8m | $21.6m
Growth
Revenue | estimate
38.9% | 39.9%
EBITDA
457.2%
EBIT
426.0%
Net Income
111.7%
Free Cash Flow
64.1%
Margin
Gross
71.0%
EBITDA
24.5%
EBIT
24.0%
Net
25.9%
Free Cash Flow | ex SBC
12.0% | 4.3%
More
EPS
$2.3
FCF per Share
$1.1
Short interest
13.9%
Employees
763
Rev per Employee
$500.0k

CareDx, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a CareDx, Inc. forecast:

10x Buy
77%
3x Hold
23%

Analyst Opinions

13 Analysts have issued a CareDx, Inc. forecast:

Buy
77%
Hold
23%

CareDx, Inc. Events

Past Events
OCT
29
Q3 2026 Earnings Call
18 days ago
JUL
30
Q2 2026 Earnings Call
4 months ago
JUN
8
Goldman Sachs 47th Annual Global Healthcare Conference 2026
5 months ago
APR
28
Q1 2026 Earnings Call
7 months ago
FEB
24
Q4 2025 Earnings Call
9 months ago
FEB
12
Special Call - CareDx, Inc.
9 months ago
NOV
4
Q3 2025 Earnings Call
about one year ago

Financial data from CareDx, Inc.

Sep '26
+/-
%
497 497
39% 39%
100%
- Direct Costs 144 144
25% 25%
29%
353 353
46% 46%
71%
- Selling and Administrative Expenses 147 147
29% 29%
30%
- Research and Development Expense 84 84
23% 23%
17%
122 122
457% 457%
24%
- Depreciation and Amortization 2.31 2.31
10% 10%
0%
EBIT (Operating Income) EBIT 119 119
426% 426%
24%
Net Profit 129 129
112% 112%
26%

In millions USD.

Don't miss a Thing! We will send you all news about CareDx, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CareDx, Inc. Stock News

Neutral
Investors Business Daily
●
7 days ago
Cathie Wood's ARK Invest bought and sold medtech shares Friday. She also bought shares of an unconventional AI chipmaker — an unpopular one at that.
Neutral
Business Wire
●
10 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the award of inducement grants. On November 5, 2026, as an inducement material to acceptance of employment with CareDx, 21 new employees were awarded restricted stock units (RSUs) for an aggregate of 33,375 shares ...
Neutral
Business Wire
●
14 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the publication of a new analysis from the Kidney Allograft Outcomes AlloSure Registry (KOAR), a landmark multicenter study, in the journal Transplantation. The third manuscript from KOAR investigated the correlati...
More CareDx, Inc. News

Company Profile

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Head office United States
CEO Mr. Hanna
Employees 763
Founded 1998
Website www.caredx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today